Aromatic Amino Acid Metabolism in the Pathogenesis of Kwashiorkor
2 other identifiers
observational
82
1 country
1
Brief Summary
This research may explain whether a shortage of three special compounds called aromatic amino acids is responsible for the severe illness and high death rate of children with the kwashiorkor type of malnutrition and whether supplying adequate amounts of these compounds in the treatment diet will speed up recovery from this condition. We propose that decreased availability of the aromatic amino acids may be the reason why children with kwashiorkor are sicker and more difficult to treat.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2006
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2006
CompletedFirst Submitted
Initial submission to the registry
January 30, 2007
CompletedFirst Posted
Study publicly available on registry
January 31, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2010
CompletedFebruary 26, 2020
February 1, 2020
January 30, 2007
February 24, 2020
Conditions
Eligibility Criteria
82 children aged 6 to 18 months and diagnosed with severe protein-energy malnutrition. By the Wellcome Classification patients will have marasmus (\< 60 % weight/age and no edema), marasmic-kwashiorkor (\< 60 % weight/age plus edema) or kwashiorkor (\< 80 % weight/age plus edema)
You may qualify if:
- Malnourished children between 6 to 18 months of age.
- To standardize for degree of malnutrition, only patients whose weight is \< 80 % of that expected for age will be enrolled. By the Wellcome Classification (22), enrolled patients will have marasmus (\< 60 % weight/age and no edema), marasmic-kwashiorkor (\< 60 % weight/age plus edema) or kwashiorkor (\< 80 % weight/age plus edema).
- Presence of infection at admission. Infection will be defined by the presence of two or more of the following: Leukocyte count \>11,000 cells/dl, temperature at admission \> 99 oF, positive blood or urine cultures.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tropical Metabolism Research Unit, University of the West Indies
Mona, Kingston, Kingston-7, Jamaica
Biospecimen
plasma, expired breath
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CROSSOVER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, Pediatrics-Nutrition
Study Record Dates
First Submitted
January 30, 2007
First Posted
January 31, 2007
Study Start
September 1, 2006
Study Completion
June 1, 2010
Last Updated
February 26, 2020
Record last verified: 2020-02